AstraZeneca cancels UK plant after subsidies cut
"Following protracted discussions with the government, we are no longer pursuing our planned investment," planned for Speke in Liverpool, northwest England, a company spokesperson told AFP.
PREMIUM World
AstraZeneca multinational pharmaceutical and biotechnology company. (AFP)
By NewVision Reporter
Journalists @NewVision
________________
LONDON - UK pharmaceutical giant AstraZeneca announced Friday that it was abandoning plans to build a £450 million ($560 million) vaccine plant, delivering a major blow to the